St. Boniface Hospital | Cardiology Research

Research site

(Unclaimed)

Location

409 Tache Avenue, Winnipeg, Manitoba, Canada

Site insights

Top conditions

Top treatments

Tranexamic Acid

Bococizumab

saline

Clindamycin

Ziltivekimab

Vancomycin

bupivacaine

Finerenone

morphine

Sildenafil

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 75 total trials

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Enrolling

Heart Failure

Drug: Placebo

Drug: Ziltivekimab

Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT)

This is a multi-center, open-label, prospective single-arm study of reversal of the antiplatelet effects of ticagrelor with bentracimab (PB2452) in p...

Enrolling

Hemorrhage

Invasive Procedure

Drug: Bentracimab (PB2452) Infusion

CLiCK in the Critical Care Unit

Insertion of a central venous access device (CVAD) allows clinicians to easily access the circulation of a patient to administer life-saving interven...

Enrolling

Central Venous Catheter Related Bloodstream Infection

Central Venous Catheter Thrombosis

Device: 4% EDTA

Device: Saline

Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction (REFINE-ICD)

This study will assess whether an implantable defibrillator will increase the likelihood of survival in patients who have had a heart attack, have ab...

Enrolling

Myocardial Infarction

Sudden Death

Other: Usual care

Device: Implantable Cardioverter Defibrillator + Usual Care

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function (PROTECT IV)

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided hea...

Enrolling

Coronary Artery Disease

Left Ventricular Dysfunction

Device: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®

Device: IABP Intra-aortic balloon pump

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19 (NOVATION-1)

This study is a randomized, double-blind, multicenter, placebo-controlled trial to evaluate the safety and efficacy of a novel therapeutic agent, Nov...

Enrolling

Covid19

Biological: Placebo

Biological: Novaferon

Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial (CATCO)

This study is an adaptive, randomized, open-label, controlled clinical trial, in collaboration with countries around the world through the World Heal...

Active, not recruiting

COVID-19

Drug: LSALT Peptide

Drug: Imatinib